Precision therapies for rare cancers - 23 Feb 23 скачать в хорошем качестве

Precision therapies for rare cancers - 23 Feb 23

This webinar is the final webinar in which we explore how precision cancer medicine is being applied to rare cancers. Precision medicine looks at the genetic and molecular characteristics of a patient’s unique tumor to identify the tumor’s specific weaknesses. Once that level of identification is possible, custom-selected treatments that attack those specific vulnerabilities have great potential to improve patient outcomes. In this discussion, Mark Furth, Scientific Director of the Fibrolamellar Cancer Foundation, leads a group of distinguished panelists in a conversation about the science and challenges behind the development of different types of targeted therapy and immunotherapy. Panelists include: Nabeel Bardeesy, PhD of Massachusetts General Hospital Razelle Kurzrock, MD of the Medical College of Wisconsin (MCW) John Scott, PhD of the University of Washington School of Medicine.